SCHEMBL13571069

SCHEMBL13571069

CCCc1cc(C=O)ccc1C#N

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.37
AR P10275 1/20 0.36
ALDH1A3 P47895 4/20 0.36
ALDH3A1 P30838 4/20 0.36
TSHR P16473 1/20 0.33
PDE3B Q13370 1/20 0.33
PDE3A Q14432 1/20 0.33
EGFR P00533 1/20 0.33
FDPS P14324 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
KDM4E B2RXH2 1/20 0.32
PTGS2 P35354 1/20 0.32
RAB9A P51151 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13571237 0.88 ALDH1A1 (0.39) ALDH1A1ARALDH1A3ALDH3A1TSHR
SCHEMBL7117400 0.78 ALDH1A1 (0.42) ALDH1A1ALDH1A3ALDH3A1TSHRFDPS
SCHEMBL20187006 0.77 KDM4E (0.49) ALDH1A1ARPDE3BPDE3AHSD17B10
SCHEMBL13630983 0.77 ALDH1A1 (0.40) ALDH1A1ALDH1A3ALDH3A1TSHRPDE3B
SCHEMBL14477876 0.77 ALDH1A1 (0.41) ALDH1A1ALDH1A3ALDH3A1TSHRFDPS
SCHEMBL20183933 0.75 ALDH1A3 (0.42) ALDH1A1ALDH1A3ALDH3A1TSHRFDPS
SCHEMBL7120865 0.75 ALDH1A1 (0.40) ALDH1A1ALDH1A3ALDH3A1TSHRFDPS
SCHEMBL27986031 0.75 CNR1 (0.41) ALDH1A1ARTSHRHSD17B10KDM4E
SCHEMBL18179347 0.75 AR (0.43) ALDH1A1ARPDE3BPDE3A
SCHEMBL24025599 0.75 ALDH1A1 (0.37) ALDH1A1TSHREGFRTDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012152983-A1 PHENYL- SULFONYL DERIVATIVES AS MEDIATORS OF TRPA1 RECEPTOR ACTIVITY FOR THE TREATMENT OF PAIN ORION CORPORATION (FI) 2012-11-15 WO disclosed
EP-2520566-A1 New Pharmaceutical Compounds Orion Corporation (FI) 2012-11-07 EP disclosed